172 related articles for article (PubMed ID: 32842535)
1. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: Learning Curve Based on Surgical and Oncological Outcomes.
Mielko J; Rawicz-Pruszyński K; Sędłak K; Gęca K; Kwietniewska M; Polkowski WP
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32842535
[TBL] [Abstract][Full Text] [Related]
2. Cytoreductive surgery with a hyperthermic intraperitoneal chemotherapy program: Safe after 40 cases, but only controlled after 140 cases.
Voron T; Eveno C; Jouvin I; Beaugerie A; Lo Dico R; Dagois S; Soyer P; Pocard M
Eur J Surg Oncol; 2015 Dec; 41(12):1671-7. PubMed ID: 26461254
[TBL] [Abstract][Full Text] [Related]
3. Multidimensional analysis of the learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies.
Kusamura S; Baratti D; Deraco M
Ann Surg; 2012 Feb; 255(2):348-56. PubMed ID: 22202584
[TBL] [Abstract][Full Text] [Related]
4. Practice patterns, attitudes, and knowledge among clinicians regarding hyperthermic intraperitoneal chemotherapy and pressurized intraperitoneal aerosol chemotherapy: a national survey by Indian society of peritoneal surface malignancies (ISPSM).
Somashekhar SP; Rohit KC; Deo SVS; Ashwin KR
Pleura Peritoneum; 2020 Sep; 5(3):20200120. PubMed ID: 33364340
[TBL] [Abstract][Full Text] [Related]
5. Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: analysis of two centres.
Kusamura S; Baratti D; Virzì S; Bonomi S; Iusco DR; Grassi A; Hutanu I; Deraco M
J Surg Oncol; 2013 Mar; 107(4):312-9. PubMed ID: 22926536
[TBL] [Abstract][Full Text] [Related]
6. Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies.
Passot G; Bakrin N; Isaac S; Decullier E; Gilly FN; Glehen O; Cotte E
Eur J Surg Oncol; 2014 Aug; 40(8):957-62. PubMed ID: 24209429
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cytoreductive surgery and HIPEC for peritoneal surface malignancies: analysis of 384 consecutive cases.
Narasimhan V; Das A; Warrier S; Lynch C; McCormick J; Tie J; Michael M; Ramsay R; Heriot A
Langenbecks Arch Surg; 2019 Aug; 404(5):527-539. PubMed ID: 31377856
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Peritoneal Surface Malignancies with Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC): Experience in Israel.
Ben-Yaacov A; Nizri E; Lahat G; Berger Y; Sadot E; Lavi R; Zippel D; Sebbag G; Avital I; Hoffman A; Gutman M; Halevy A; Schneibaum S; Ben-Ari G; Benchimol D; Klausner J; Nissan A;
Indian J Surg Oncol; 2019 Feb; 10(Suppl 1):19-23. PubMed ID: 30886488
[TBL] [Abstract][Full Text] [Related]
9. Toxicity profile of chemotherapy agents used in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies.
Somashekhar SP; Yethadka R; Kumar C R; Ashwin KR; Zaveri S; Rauthan A
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):577-581. PubMed ID: 31677939
[TBL] [Abstract][Full Text] [Related]
10. Current Management of Peritoneal Carcinomatosis From Colorectal Cancer: The Role of Cytoreductive Surgery and Hyperthermic Peritoneal Chemoperfusion.
Nassour I; Polanco PM
Curr Colorectal Cancer Rep; 2017 Apr; 13(2):144-153. PubMed ID: 28890671
[TBL] [Abstract][Full Text] [Related]
11. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Girshally R; Demtröder C; Albayrak N; Zieren J; Tempfer C; Reymond MA
World J Surg Oncol; 2016 Sep; 14(1):253. PubMed ID: 27678344
[TBL] [Abstract][Full Text] [Related]
12. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center.
Yu HH; Yonemura Y; Hsieh MC; Mizumoto A; Wakama S; Lu CY
Cancer Manag Res; 2017; 9():513-523. PubMed ID: 29089784
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal malignancy: preliminary results of a multi-disciplinary teamwork model in Asia.
Wang TY; Chen CY; Lu CH; Chen MC; Lee LW; Huang TH; Hsieh MC; Chen CJ; Yu CM; Chuang HC; Liao TT; Tseng CW; Huang WS
Int J Hyperthermia; 2018 May; 34(3):328-335. PubMed ID: 28562119
[TBL] [Abstract][Full Text] [Related]
14. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.
Wu HT; Yang XJ; Huang CQ; Sun JH; Ji ZH; Peng KW; Zhang Q; Li Y
World J Surg Oncol; 2016 Sep; 14(1):246. PubMed ID: 27633880
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Laparoscopy in the Pre-operative Assessment of Patients Undergoing Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancies.
Seshadri RA; Hemanth Raj E
Indian J Surg Oncol; 2016 Jun; 7(2):230-5. PubMed ID: 27065714
[TBL] [Abstract][Full Text] [Related]
16. Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis.
Wu X; Li Z; Li Z; Jia Y; Shan F; Ji X; Bu Z; Zhang L; Wu A; Ji J
J Surg Oncol; 2015 Jun; 111(7):840-7. PubMed ID: 25864884
[TBL] [Abstract][Full Text] [Related]
17. Current practices of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies: an international survey of oncologic surgeons.
Yoo HJ; Hong JJ; Ko YB; Lee M; Kim Y; Han HY; Song YJ; Lim MC; Park SY
World J Surg Oncol; 2018 May; 16(1):92. PubMed ID: 29764445
[TBL] [Abstract][Full Text] [Related]
18. Accelerating the learning curve in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using an external mentor model.
Ansari N; Brown KGM; McBride KE; Steffens D; Koh CE; Young CJ; Solomon MJ; Moran BJ
ANZ J Surg; 2019 Sep; 89(9):1097-1101. PubMed ID: 31280498
[TBL] [Abstract][Full Text] [Related]
19. Does early post-operative intraperitoneal chemotherapy (EPIC) for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) make a difference?
Tan GH; Ong WS; Chia CS; Tham CK; Soo KC; Teo MC
Int J Hyperthermia; 2016 May; 32(3):281-8. PubMed ID: 26862667
[TBL] [Abstract][Full Text] [Related]
20. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.
Sardi A; Jimenez WA; Nieroda C; Sittig M; Macdonald R; Gushchin V
Eur J Surg Oncol; 2013 Nov; 39(11):1207-13. PubMed ID: 24007834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
